Adult Cancers

Nearly 10 million people around the world die from cancer each year. As many as 70% are in low-and-middle-income countries. We seek to strengthen cancer care systems and community supportive services for heavily burdened populations in Brazil, India, ten countries in Sub–Saharan Africa, and across the United States.

The Multinational Lung Cancer Control Program (MLCCP) is a global collaboration to improve awareness, knowledge, and access to care for unmet needs for lung cancer. These programs stimulate and catalyze improvement within health systems to improve cancer services and provide us with the successful framework to also remain dedicated to initiatives for other high disease burden cancers prevalent in the countries where we are focused.

Global cancer disparities


United States

Despite lung cancer being the leading cause of cancer death, only a very small percentage of eligible patients are currently being screened on an annual basis.

Brazil
Northeast regions have few cancer treatment centers, where populations experience poorer health outcomes.

India
Many cases of lung cancers present in late stages, leading to high mortality rates. There is also a high incidence of tuberculosis, which can lead to misdiagnosis.

Africa
There is limited data on lung cancer and a high death rate due to late presentation and misdiagnosis, and a lack of treatment protocols. 

Our impact

We are working to fund and support models of care that are replicable and scalable so that the achievements of our grantees can benefit patients everywhere.

  • In the United States, we are leveraging over a decade of history focused on advancing lung cancer care in the US. BMS Foundation is committed to continue build equitable healthcare system capacity.
  • In Brazil, we are working to improve access to cancer care services for underserved patients by executing strategic grant making aligned with an innovative lung cancer control program focused on early diagnosis.
  • In India, as lung cancer becomes a national priority, the BMS Foundation is working to improve patient outcomes by challenging disease related stigma and building care pathways for patients.
  • In Sub-Saharan Africa, we continue to add to our extensive body of knowledge on lung cancer, cervical cancer, and multiple myeloma by investing in awareness, screening, care, and research interventions in different cultural and health resource settings to improve cancer care.  Our MLCCP program in Africa has already achieved 39 published articles and 49 abstracts, and includes eleven post-doctorate/fellows, eight PhD candidates, one PhD graduate, and eleven MMedSci graduates.

Greenwood Leflore Hospital

Greenwood Leflore Hospital in Mississippi developed a model to detect and diagnose cancer much earlier. Can their work in this rural community impact other underserved populations around the world?